The reaction path of allyl anion 2, derived from unsaturated ester 1, is governed by substituents R1 -R4. An understanding of the reaction mechanisms involved has allowed the appropriate design of substrates for specific applications leading to the synthesis of various bioactive natural products.
In exploring the scope of this cyclization reaction further observations have revealed other competing reaction pathways as summarized below. First, when substituent R1 is an ester moiety anion 2 takes an alternative path where, instead of cyclization, it undergoes a regiospecific 12-acyl migration to give the ester enolate 6, thence product 7.2 Placing the ester group at R3 also inhibits ring formation as a 5-enolendo-exotrig cyclization of the dienolate 8 would be a disfavoured process.3 However the strain in the transition state for the cyclization of systems such as 8 is diminished in the case of it's homologue, 8b, which is found to readily cyclize to the 6-membered ring keto ester 9b.4 Also as might be expected, placement of the ester group at the terminal of the allyl functionality as shown in 10 (2, R4 = COOMe) facilitates cyclization (via a 5-enolexo-exo-trig process) to provide the enone 11.4
An understanding of the reactions shown above has enabled us to design substrate molecules that can be manipulated to react to yield target bioactive natural products. For example, chemical modification employing host-guest chemistry (by the use of anthracene adducts) coupled with the above annulation reaction has led to the synthesis of labile a-methylene cyclopentenones (e.g. 5 , R1,R2 = methylene) including naturally occurring cyclopentenoid antibiotics, viz: methylenomycin B 12,s methylenomycin A 13 and deepoxy-4,5-didehydromethylenomycin A 146 and sarkomycin 15.7
The synthesis of vinylnaphthoquinone 19 (Scheme 2) was accomplished by taking advantage of the 12-acyl migration along the allylic frame-work described above by conversion of the keto group to the corresponding alcohol followed by LDA treatment and re-oxidation with PDC to provide the desired spiro-diketone 28. On the other hand, the acetal30 could be subjected to cyclization to give 31 and finally 28, or converted to the corresponding keto allyl ester (e.g. 26) to be manoeuvred along the foregoing reaction pathway just described.9 The success of the methyl acrylate -anthracene adduct in the synthesis of a-methylene cyclopentenone antibiotics (12 -15) prompted an investigation of the masked itaconate adduct 32. Here, it was reckoned that 32, already known and easily prepared in very high yield from dimethyl itaconate and anthracene,'o should act as the perfect synthetic equivalents A, B and C shown in Scheme 5. True to expectation adduct 32 has since proved its worth in organic synthesis. For example, the soughtafter electron deficient diene 33 and the a-methylene cyclopentanone (34, X = CH2) and lactam (34, X = NR) were all easily prepared from adduct 32. In fact, the syntheses of diene 3311 and sarkomycin 157 from 32 are arguably among the most efficient methods reported to date.
The use of adduct 32 as B and C synthetic equivalents also appeared quite attractive due to it's anticipated synthetic versatility. Close examination revealed that the functionalities of type B and C are quite suitable for the assembly of various bioactive methylene lactones and bilactones that have been isolated from microorganisms, e.g. methylenolactocin 35a,12 protolichesterinic acid 35b,13 canadensolide 36a,14 and sporothriolide 36b.15 Moreover, certain lichen components such as nephrosteranic and roccellaric acids, 37a16 and 37b17 respectively, also looked amenable to preparation from adduct 32 without much apparent difficulty. 
The synthesis of the a-methylene lactones 47a and 47b (methyl esters of 35a and 35b respectively) was accomplished in a straightforward manner by treating the ester enolate 38, derived from adduct 32, with the corresponding aldehydes which resulted in two major products, 43 and 44, being formed in almost equal amounts. The cis-stereochemical relationship between substituents R and -COOMe in both products was determined by their nmr absorptions which included data from NOE experiments. This stereochemical outcome can be explained in terms of the two chair-like transition states shown in 39 and 40, in which all large substituents occupy equatorial positions (Scheme 6).1* Equilibration of the spiro-lactones (MeONa / MeOH, r.t.) followed by flash vacuum pyrolysis (of either pure samples or a mixture of 45 and 46) yielded the racemic methylene lactone 47. It turns out that the chair-like transition states of the aldol condensation of ester enolate 38 which control the cis-relative stereochemistry between groups R and -COOMe in the products 43 and 44 are, in fact, ideally suited for the synthesis of canadensolide and sporothriolide, 36a and 36b respectively. According to this constraint, a condensation between the adduct 32 with an aldehyde, e.g. 50, would provide the cissubstituted lactone 49 which upon deprotection of the alcoholic function would lactonize to give the bilactone 48, hence 36. It should be noted that adduct 32 and aldehyde 50 are functioning here as synthetic equivalents of the type C and D respectively (Scheme 7). A synthesis of canadensolide and epi-canadensolide in this manner (method in Scheme 7) has been achieved, and represents an efficient alternative methodology for the synthesis of the bilactone skeleton such as 36.
To conclude: The research described above has enabled us to fully understand the mechanisms of the cyclization reaction involving the ally1 anion intermediate, which has led to its consequent utilization in organic synthesis. Applications of the reaction using functionalized ester adducts, in particular the adduct 32, has resulted in a good number of synthesis of various bioactive natural products.
